[
  {
    "chunk_id": 0,
    "text": "H Y P E R T E N S I O N Prognostic Value of Blood Hypertension Variability and Average Blood Hypertension Levels in Patients With Hypertension and Diabetes GIANFRANCO PARATI, MD, FESC 1, 2, 3 CAROLINA LOMBARDI, MD, PHD 3 relationship of elevated blood pressure levels and JUAN EUGENIO OCHOA, MD 2, 3 GRZEGORZ BILO, MD, PHD 3 type 2 Diabetes with risk of target-organ PAOLO SALVI, MD, PHD 3 damage and CV events without any evidenceofBPthresholdlevel(811). Inline with these findings, evidence has also been provided that in hypertensive paE levatedbloodpressure(blood pressure)isamaTheaimofthepresentarticleistoreview tients with coexisting type 2 Diabetes, jor risk factor for cardiovascular the available evidence on the prognostic tightercontrolofclinicBPisparticularly (CV)eventsandmortality(1)anda importance of blood pressure mean levels and of blood pressure important in order to improve CV proleading contributor to the global disease variability (BPV) estimates and to crititection (1223). Notwithstanding the burden (2). Overwhelming evidence is cally evaluate whether antihypertensive current recommendation that OBP meanowavailableshowingthatBPmeasured treatment strategies should be targeted surementremainsthecornerstoneofhyin the office shows a linear relationship at reducing not only average blood pressure levels pertension diagnosis and management, withanumberofCVandrenaloutcomes butalsothedegreeofBPVinordertoopthereisnowageneralconsensusthatiso- aswellaswithoverallmortalityandthat timizeCVprotectionindiabeticpatients. lated OBP readings alone are no longer lowering of office blood pressure (OBP) with treatsufficient. This is because of several ment is effective in reducing morbidity Prognostic value of OBP values well-acknowledgedlimitationsthatcharandmortality(3, 4). However, application Consistent evidence from observational acterize OBP measurements, including over the last 40 years of techniques for studies has indicated that the risk of CV theirinabilitytotrackthedynamicbehavout-of-office blood pressure monitoring including morbidityandmortalityhasastrongand ior of blood pressure, the inherent inaccuracy of the home blood pressure monitoring (HBPM) and 24-h continuous relationship with OBP levels technique, the operator dependence of ambulatory blood pressure monitoring (ABPM) has (3), without any evidence of a threshold the auscultatory technique (observer ledtofurtherimportantfindings. Inpardowntoatleast115/75mmHg(4). Furbias, digit preference), variable interferticular, 1)averageBPmeasuredineverythermore, large meta-analyses of major ence by the white coat effect, and the daylifeconditionsmaybeanevenbetter interventional trials in hypertensive subinabilityofthisapproachtocollectinfor- predictor of CV outcomes than isolated jectshaveshownthatloweringOBPlevels mationonBPduringsubjectsusualactivOBP readings and 2) the extent of flucconferssignificantCVprotectionregard- itiesandoveralongperiodoftime. tuations of blood pressure over time may provide less of the drug class used with a direct Are out-of-office mean blood pressure levels supeadditional, independent prognostic inrelationship between the degree of OBP rior to OBP in predicting CV outformation compared with both isolated loweringandthemagnitudeofriskreduccomes? Theintroductionofout-of-office office readings and average ambulatory tionformostoftheoutcomesconsidered blood pressure measurement techniques (i. e. , HBPM blood pressure(ABP)levels, respectively. Thesefind- (7). and 24-h ABPM) over the past four ingsareofupmostrelevanceinthecaseof Patients with Diabetes and elevadecades has significantly improved the diabetic patients who are characterized tion in clinic blood pressure levels are at higher CV management of hypertension, overcomby a significantly higher risk of CV riskcomparedwithnondiabeticindividingsomelimitationsofOBP. Noninvasive events compared with nondiabetic indiuals (810). Evidence on this has been ABPM techniques, based on automated viduals, with Diabetes itself currently provided from several studies, showoscillometric arm cuff blood pressure readings, are consideredaCVdiseaseequivalent(5, 6). ing a continuous direct and synergic nowadays widely available and provide blood pressure measurements throughout the 24 h, c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c not only during daytime, but also at From1CardiovascularMedicine, UniversityofMilano-Bicocca, Milan, Italy; the2DepartmentofHealthScinight, when blood pressure levels are known to bear ences, UniversityofMilano-Bicocca, Milan, Italy; andthe3DepartmentofCardiology, S. LucaHospital, the strongest prognostic value (2428). IstitutoDiRicoveroeCuraaCarattereScientifico, IstitutoAuxologicoItaliano, Milan, Italy. Although, compared with ABPM, selfCorrespondingauthor: GianfrancoParati, gianfranco. paratiunimib. it.",
    "word_count": 589,
    "char_count": 4885,
    "sentence_count": 20,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 0,
      "total_chunks": 16,
      "position": "1/16",
      "content_type": "monitoring",
      "content_type_confidence": 4,
      "medical_entities": [
        "antihypertensive",
        "monitoring"
      ],
      "entity_count": 2
    }
  },
  {
    "chunk_id": 1,
    "text": "IstitutoDiRicoveroeCuraaCarattereScientifico, IstitutoAuxologicoItaliano, Milan, Italy. Although, compared with ABPM, selfCorrespondingauthor: GianfrancoParati, gianfranco. paratiunimib. it. measurements of blood pressure by patients at home Thispublicationisbasedonthepresentationsfromthe4thWorldCongressonControversiestoConsensusin cannotprovidetheextensiveinformation Diabetes, ObesityandHypertension(CODHy). TheCongressandthepublicationofthissupplementwere madepossibleinpartbyunrestrictededucationalgrantsfromAbbott, AstraZeneca, BoehringerIngelheim, on daily life blood pressure values yielded by 24-h Bristol-MyersSquibb, EliLilly, EthiconEndo-Surgery, Janssen, Medtronic, NovoNordisk, Sanofi, and ambulatory recordings, they do give before mealsTakeda. curate and frequent out-of-office blood pressure DOI: 10. 2337/dcS13-2043 measurements over a single day, several 2013bytheAmericanDiabetesAssociation. Readersmayusethisarticleaslongastheworkisproperly cited, theuseiseducationalandnotforprofit, andtheworkisnotaltered. See days, weeks, ormonthsinausuallifesetlicenses/by-nc-nd/3. 0/fordetails. ting, representing an ideal tool not only S312 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates for a population-wide diagnostic apand non-CV mortality (2426, 4145) ABPM, notablyduetothesmallernumber proach to hypertension but also for blood pressure both in a general population (25 of HBPM-related outcome studies availmonitoring over long-term follow-up 28, 43, 45) and in hypertensive patients ablesofar(29). (29). Both HBPM and ABPM are thus alone (24, 28, 40, 42, 44). Of relevance, able to provide blood pressure measurements in the compared with awake or 24-h blood pressure BPV: a complex phenomenon patients natural environmentdon one means, nocturnal blood pressure levels have been AlthoughtheadverseCVconsequencesof hand, detecting blood pressure changes in real-life shown to be superior in predicting hypertension are largely considered deconditions, and on the other hand preCV morbidity and mortality (24 pendent on average blood pressure values, evidence venting the alarm reaction associated 26, 28, 46, 47), the development of CV provided by observational studies and with OBP measurement, responsible for events (24, 25, 4042), and overall morclinicaltrialshasalsoindicatedapossible thewhitecoateffect(30). Becauseofthese tality(2426, 41, 44, 45). ThisisnotsurroleofincreasedBPVinthisregard. BPis features, disagreement between OBP and prising given that a patients nocturnal characterizedbymarkedshort-termflucout-of-office blood pressure measurements (either blood pressure level, without the pressor effects of tuationswithinthe24h(includingthose withABPMorHBPM)isfrequentlyreportphysical activity, emotional stress, and occurringinan apparentlyrandomfashed, leading to the identification of two other environmental factors that usually ion over seconds or minutes and those conditions where blood pressure status is differently occurduringtheday, maybemorereprofollowing the circadian rhythm of activclassified by these methods: white-coat ducible and representative of a patients ity). Significant blood pressure variations have also hypertension, also termed isolated office actualBPlevelsandorgandamagestatus. been shown to occur over more prohypertension (elevated OBP and normal Also, inthecaseofdiabeticsubjectsoutlonged periods of time (i. e. , between ABP or HBP), and masked hypertension of-office blood pressure values obtained through days, weeks, months, and seasons and (normalOBPandelevatedambulatoryor ABPM may be a powerful tool for a betevenyears). BPVistheresultofcomplex homeBPlevels)(31, 32). Identificationof ter stratification of CV risk related to interactions between extrinsic environthesetwoconditions, thelatterinparticelevated blood pressure. In support of this, several mentalandbehavioralfactorswithintrinular, is of relevance since several studies studieshaveshownABPvaluestobebetsic CV regulatory mechanisms (humoral havedemonstratedaworseCVprognosis ter correlated with target-organ damage and neural central or reflex influences) among subjects with masked hyper- (48, 49) and to be better predictors notyetcompletelyunderstood. Measures tension compared with those with isoof CV events (50) than OBP in diabetic ofBPVcanbeobtainedthroughdifferent lated office hypertension (31, 32). In patients. methods, i. e. , continuousbeat-to-beatBP support of the prognostic value of outWhile all the above evidence Highrecordings, repeated conventional OBP of-office mean blood pressure levels, several obserlightsthesuperiorityofABPMinstratify- measures, 24-h ABPM, or HBPM over vational studies either in diabetic or ing blood pressure-related risk of hypertensive longer time windows. Depending on the nondiabetic populations have provided patients, in particular of those with dimethod and time interval considered for consistent evidence on the superiority abetes, the evidence on the prognostic its assessment, the clinical significance of ambulatory and home blood pressure levels over relevance of treatment-induced reducand prognostic implications of a given conventional OBP in predicting CV tionsinABPcompared with thatofOBP measureofBPVmayindeedsubstantially events (see below), leading major interreductions is limited. Nevertheless, it differ(Fig. 1).",
    "word_count": 600,
    "char_count": 5412,
    "sentence_count": 31,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 1,
      "total_chunks": 16,
      "position": "2/16",
      "content_type": "monitoring",
      "content_type_confidence": 3,
      "medical_entities": [],
      "entity_count": 0
    }
  },
  {
    "chunk_id": 2,
    "text": "Nevertheless, it differ(Fig. 1). national hypertension management appears that compared with OBP, ABP guidelines to recommend the use of reductions are more closely related to Short-term BPV: measurement, ABPM and HBPM in clinical practice regression of subclinical cardiac organ mechanisms, and prognostic as a complement to conventional OBP damage (36) and to reductions in the relevance measurements(1, 29, 33, 34). risk of fatal and nonfatal CV events and Assessmentofshort-termBPV. ThedySuperior prognostic value of ABP over ingeneralmortality(51)inparticularwhen namicbehaviorofBPvaluesoverthe24-h OBP. As mentioned above, a major adnighttimeBPlevelsareconsidered(52). period was first shown through use of vantage of ABPM overOBPis its ability Superior prognostic value of home blood pressure intra-arterial blood pressure monitoring in ambulant toprovidemoreaccuratemeasurements over OBP. In general, the prognostic subjects (6567). Although an accurate of blood pressure and to better track blood pressure changes value of HBPM has also been found to assessmentofshort-termBPVwithinthe induced by antihypertensive treatment besuperiortothatofOBPmeasurements 24hrequirescontinuousBPmonitoring, aswellastheactualcoverageofagiven in hypertensive patients with or without its evaluation is also possible (although treatmentoverthe24-hperiod. Itisthus Diabetes(25, 27, 36, 41, 5359). Whenavlessprecisely)throughuseofintermittent, notsurprisingthatbothcross-sectional eragedoverafewdays, homeBPmeasurenoninvasive 24-h ABPM. From these reand longitudinal studies have shown a ments have been shown to significantly cordings, itispossibletocalculatetheSD superiorprognosticvaluefor24-h, daypredict the development of major CV of average systolic (SBP), diastolic (DBP), time, andnighttimeaverageABPvalues events (myocardial infarction, stroke, and mean blood pressure values over the 24 h, with compared with OBP. In these studies, and CV death), all-cause mortality, prothedaytimeandthenighttimeperiodssep- compared with OBP measures ABP valgression of chronic Kidney disease (60), aratelyconsidered(68). Giventheopposite ues were more closely associated with and functional decline in the elderly, clinical significance of short-term BPV hypertensive subclinical organ damage with HBPM being a better predictor of within daytime or nighttime on one side, andwithitschangesafterantihypertenCVmortality (fatal CVevents) thanOBP and of slower changes between day and sive treatment (3539), and more imin most (25, 5355, 5962) although not nightontheotherside, severalnewmethportantly, it was also more effective in in all (63) studies. As a general remark, ods for the separate assessment of slower predicting the development of CV however, there is less evidence supportcircadianBPfluctuationsandoftheresid- events (24, 25, 4042) as well as CV ingtheprognosticvalueofHBPMthanfor ual faster blood pressure changes occurring during care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S313 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome daytimeornighttimehavebeenproposed. are often inextricably intertwined. blood pressure increased compared with that in hyperThesemethods, whichallowexclusionof variations in the very short term (i. e. , tensivesubjectswithoutdiabetes(79). Althe contribution of circadian blood pressure changes beat to beat) and in the short term (i. e. , though fasting Blood glucose levels have fromtheestimateofoverall24-hBPV, inwithin24h)mainlyreflecttheinfluences beenfoundtobeamajordeterminantfor clude assessment of 1) weighted SD of ofcentralneuralfactorseitherinresponse thisincreaseinBPV, otherfactorssuchas the 24-h mean value (i. e. , the average of to behavioral challenges or as a result of diabetic autonomic dysfunction (which daytime and nighttime blood pressure SD, each rhythmic influences originating in the may induce significant impairment in weighted for the duration of the day and central nervous system, as well as the baroreflexsensitivity)andincreasedartenight periods, respectively) (69), 2) soinfluences of reflex autonomic modularialstiffnessmightalsoplayanimportant called average real variability (average tion (i. e. , an increased central symparole (7981). Interestingly, some studies of absolute differences between consecuthetic drive and reduced sensitivity of in the diabetic population have shown tivereadings)(70), or3)residualspectral arterial and cardiopulmonary reflexes plasma norepinephrine levels to be dicomponents of BPV (obtained by removmaybothleadtoanincreasedBPV)(73 rectly correlated to nighttime systolic ing main slower cyclic components 76). Inthiscontext, alsochangesinelastic BPV, suggesting a potential role of symthroughFourieranalysis)(71).",
    "word_count": 565,
    "char_count": 4776,
    "sentence_count": 22,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 2,
      "total_chunks": 16,
      "position": "3/16",
      "content_type": "monitoring",
      "content_type_confidence": 5,
      "medical_entities": [
        "chronic kidney disease",
        "antihypertensive",
        "monitoring"
      ],
      "entity_count": 3
    }
  },
  {
    "chunk_id": 3,
    "text": "Inthiscontext, alsochangesinelastic BPV, suggesting a potential role of symthroughFourieranalysis)(71). Thesepaproperties of large arteries (i. e. , an inpathetic activation for the increase in rameters, which focus on short-term blood pressure creasedarterialstiffness)(77)andtheefnighttime BPV observed in the diabetic changes and are not affected by the dipfects of humoral (insulin, angiotensin II, population (82). Several studies using pingphenomenon, havebeenshowntobe bradykinin, endothelin-1, and nitric ox24-h ABPM have also indicated an inbetterpredictorsoforgandamageandCV ide)andrheological(i. e. , bloodviscosity) creased prevalence of alterations in dayrisk than the conventional 24-h SD factors(78)mayplayarole. Inaddition, blood pressure to-night blood pressure changes in diabetic patients. (69, 70, 72). fluctuations also occur in response to the In particular, an impaired nocturnal blood pressure Mechanisms of short-term BPV. The mechanicalforcesgeneratedbyventilation. fall(i. e. , nondipping)orevenincreasein results of several studies trying to disenIn diabetic patients with hypertennighttimeBP(i. e. , risingpattern)hasbeen tangle the precise contribution of husion, overallBPV(assessedthroughSDof showntobecommoninthispopulation, moral, neural, andenvironmentalfactors average 24-h, daytime, or nighttime blood pressure with aprevalence thatmay be ashighas to BPV have indicated that these factors values) has been found to be frequently 30and31%, respectively(83). Proposed Figure1dDifferenttypesofBPV, theirdeterminants, andprognosticrelevanceforCVandrenaloutcomes. AHT, antihypertensivetreatment; estimated glomerular filtration rate, estimatedglomerularfiltrationrate; end-stage renal disease, end-stagerenaldisease; MA, microalbuminuria; myocardial infarction, myocardialinfarction; SOD, subclinical organ damage. Assessed in laboratory conditions. Cardiac, vascular, and renal SOD. BPV on a beat-by-beat basis has not been routinely measuredinpopulationstudies. ReprintedwithpermissionfromParati, Ochoa, andBilo(64). S314 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates mechanisms for these abnormalities in blood pressure values but also on BPV, which may organdamage(93, 102)andincreasedrisk circadian blood pressure rhythms include alterations independently add to CV risk over and of CV events (103) and mortality inautonomicCVmodulation(whichare above the contribution of elevated mean (28, 104). The risk of CV events is even frequently associated with Diabetes) blood pressure levels. Recent reports of the InternahigherforpatientsinwhomBPincreases (84, 85) but also other conditions such tional Database on Ambulatory blood pressure in rather than decreases at night (104, 105) asobstructivesleepapnea, commonlyobrelation to Cardiovascular Outcome whilethepredictiverelevanceofextreme servedinobesediabeticsubjects(86). haveconfirmed that indices ofBPVsuch dippingremainscontroversial (104). RePrognostic significance of short-term as the weighted 24-h blood pressure SD and the markably, nondippingprofileofBPisfreBPV. The degree of BPV is in general average real variability (70) may predict quently accompanied by increased roughlyproportionaltomeanBPvalues, outcome, buttheyimprovepredictionof nocturnal meanBP levels(i. e. , nighttime and this dependence of BPV on average the composite CV events provided by blood pressure. 125/75 mmHg) (101). However, BPhasledtomethodsforassessingBPVin meanBPlevelsbyonlyasmallpercentage whether it is the reduction in nocturnal normalizedunitsaimedataccountingfor (100). Such analysis, however, is limited blood pressure dipping or the increase in absolute average blood pressure level. This can be done by by the lack of standardization of blood pressure relevel of average blood pressure at night that really computing blood pressure coefficient of variation, cordings performed in different counmatters is an issue still under investigawhile in the research setting this issue is tries. tion (28, 47). In addition, evidence is overcome by adjusting in multivariate In diabetic patients, the incidence of also available that an increased morning models the impact of BPV on clinical coronaryarterydiseasehasbeenshownto blood pressure surge is associated with a higher outcome for the concomitant influence be significantly greater in patients with incidence of CV events and mortality of mean blood pressure levels. Early studies using increased24-hsystolicBPV(67vs. 11%; (94, 95, 103, 106). However, the actual 24-hintra-arterialABPMforthefirsttime P, 0. 0005). Interestingly, nighttimesysprognostic value of morning blood pressure surge is showedthatBPV(quantifiedastheSDof tolicBPVwasanindependentriskfactor stillamatterofdebatedue, ononehand, the 24-h, day, and night mean values) for coronary artery disease (odds ratio to the difficulties in identifying the most increases from normotensive to hyper3. 1382; P, 0. 05)(82).",
    "word_count": 588,
    "char_count": 5007,
    "sentence_count": 35,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 3,
      "total_chunks": 16,
      "position": "4/16",
      "content_type": "evidence",
      "content_type_confidence": 4,
      "medical_entities": [
        "glomerular filtration rate",
        "end-stage renal disease",
        "insulin"
      ],
      "entity_count": 3
    }
  },
  {
    "chunk_id": 4,
    "text": "1382; P, 0. 05)(82). reliablemethodfordefiningandassessing tensive subjects, the increase in blood pressure SD thisparameterandontheotherhand, to being proportional to the increase in Day-to-night blood pressure profiles: assessment the significant correlation between two mean blood pressure, with no change in the coeffiand prognostic relevance features of the 24-h blood pressure profile with concient of variation (65). Interestingly, an Assessment of day-to-night blood pressure profiles tradictoryprognosticsignificance: thedeincrease in BPV was also shown within with ABPM. In addition to providing gree of morning blood pressure surge (a potentially individuals, asmeanBPlevelsofdifferent information on mean blood pressure levels and on risky phenomenon) and the degree of subperiods within the 24 h increased relativelyfastBPchangesduringselected blood pressure fall at night (a potentially protective (65). subperiods over the 24 h, ABPM also phenomenon)dacorrelationthatmakes Evidence from longitudinal and obmakes possible the identification of theclinicalinterpretationofthedegreeof servational studies has indicated that slowerBPfluctuationsoccurringbetween morningBPsurgemoredifficult. Indeed, short-term BPV within the 24 h may day and night, which are significantly theadverseprognosticimpactofablunted have a nonmarginal contribution to CV influenced both by the subjects level of or inverted nighttime blood pressure fall (which is risk. Byusingeitherintra-arterialornonactivityduringdaytimeandbythesleep/ associated with a blunted morning blood pressure invasive blood pressure monitoring, several studies wakefulnesscycle. Byconsideringthedesurgeas well) seemsdifficult toreconcile haveindeedshownthatcardiac, vascular, gree of blood pressure change from awake to sleep, with the hypothesis that an excessive andrenalorgandamageforagiven24-h different patterns of circadian blood pressure variamorning blood pressure surge is also predictive of a blood pressure mean value is more prevalent and tionmaybeidentifiedinrelationtonocworse outcome. A recent large cohort severe as 24-hBPVincreases (66, 8792) turnal blood pressure fall and morning blood pressure surge. In study in hypertensive patients showed (Fig. 2). the general population, blood pressure falls on averthat a blunted day-night blood pressure dip but not Most importantly, prospective studageby1020%ofdaytimevaluesduring an increased morning blood pressure surge was the ieshaveprovidedevidencethataninitial sleep, a phenomenon referred to as dipkey predictor of CV outcomes, probably increase in BPV within the 24 h is an ping. DippersexhibitingnighttimeBPfall becauseofthesuperiorreproducibilityof independent predictor of progression of. 20%areknownasextremedippers. In nocturnal blood pressure compared with earlysubclinical organ damage (i. e. , increased some individuals, nocturnal decrease in morning blood pressure surge (107). When focusing left ventricular mass index or carotid blood pressure is blunted (non-dippers, with a fall on a diabetic population, several studies intima-media thickness) (92, 93), CV innighttimeSBPandDBP, 10%ofdayhave indicated that a nondipping profile events (71, 72, 9497), and CV mortality time blood pressure but still presenting some reducandinparticulararisingnightBPpattern (71, 72, 9399). In particular, data from tion compared with awake blood pressure) or even maybeofrelevanceforCVprediction. In the Pressioni Arteriose Monitorate e increases (so-called risers or inverted either type 1 (102, 108) or type 2 (109 LoroAssociazioni(PAMELA)studyfound dippers) compared with daytime values 112) diabetic subjects, several studies the risk of CV death not only to be in- (101). have indicated that elevated SBP during versely related to day-night DBP fall Prognostic relevance of alterations in nighttimesleepmayprecededevelopment (Fig. 3)butalsotobearasignificantposday-to-night blood pressure changes. Therelevance of renal damage (assessed trough microitiverelationshipwithresidualshort-term of alterations in circadian blood pressure profiles for albuminuria) and contribute to progresdiastolicBPV(71). CVprognosishasbeenexploredinseveral sion of renal damage when nephropathy Overall, this evidence supports the studies. Subjects in whom nocturnal blood pressure isalreadypresent. Evidencehasalsobeen concept that the adverse CV consequenreduction is blunted have been reported provided that a nondipping pattern of cesofhighBPdependnotonlyonmean tohaveagreaterprevalenceofsubclinical blood pressure is associated with an increased care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S315 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome Figure2dA: Short-termBPVandsubclinicalorgandamage(cross-sectionalstudy). Rateandseverityoftarget-organdamageinpatientswith essentialhypertensiondividedintoquintilesofincreasing24-hmeanintra-arterialBP(MAP). Patientsineachgroupwerefurtherclassifiedintotwo categoriesaccordingtowhetherthebetween-half-hourSDofmeanintra-arterialBPwasbeloworabovetheaveragevariabilityofthegroup. Within eachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBPvalues. Foreachclass, theseverityoftarget-organdamagewasexpressedasthe S316 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates and treatment regimen remain stable.",
    "word_count": 597,
    "char_count": 5422,
    "sentence_count": 33,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 4,
      "total_chunks": 16,
      "position": "5/16",
      "content_type": "evidence",
      "content_type_confidence": 3,
      "medical_entities": [
        "nephropathy",
        "albuminuria",
        "monitoring"
      ],
      "entity_count": 3
    }
  },
  {
    "chunk_id": 5,
    "text": "diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates and treatment regimen remain stable. Thus, HBPM appears more appropriate forthelong-termassessmentofBPVand blood pressure control than repeated office or ABP measurements. Prognostic significance of day-by-day BPV. Recent studies exploring the prognostic role of BPV identified by HBPM have indicated that an increased day-byday variability in home blood pressure values is associated with a higher prevalence and severity of cardiac, vascular, and renal organ damage (120) and with an increased risk of fatal and nonfatal CV Figure3dKaplan-MeiercurvesforCVmortalityinsubjectswithday-nightDBPdifference(A) events(121, 122). Arecentcross-sectional andresidualvariability(B)above(blacklines)andbelow(graylines)themedianvalueofthe analysis in a population of never-treated population. ModifiedwithpermissionfromManciaetal. (71). hypertensive patients showed an increased day-by-day home systolic BPV mortalityrate, regardless ofdiabetestype inconstant accuracy of OBP readings to be associated with the severity of car- (113). Of note, the combination of non- (Fig. 1) (119). Thus, factors influencing diac (i. e. , left ventricular mass index), dippingandsubsequentrenalimpairment thedegreeofBPcontrol(i. e. , patientsadmacrovascular (i. e. , increased carotid inwasshowntobeassociatedwiththehigh- herenceto treatment and properdosing/ tima-media thickness), and microvascuest mortality rate (113). However, other titration of antihypertensive treatment) lar (i. e. , urinary albumin-to-Creatinine studies in type 2 diabetic subjects have orerrorsinBPmeasurementmayindue ratio) organ damage regardless of the foundmeannighttimeSBPtobeastronger courseinfluenceday-by-daybutespecially mean home blood pressure level, suggesting that predictor of organ damage and fatal and visit-to-visit BPV. In particular, patients homesystolicBPVmayaddtoprediction nonfatalvasculareventsthanthenondippoor compliance with antihypertensive ofhypertensivesubclinicalorgandamage pingpatterninnocturnalSBP(114). treatment may influence long-term BPV, over and above mean home SBP (120). as dose omission or delay in drug intake When it comes to prediction of major Long-term BPV duringthefollow-upperiodmayalsoconCV events, the Ohasama study provided blood pressure has been shown to exhibit important tribute to an increased day-by-day and the first evidence that an increased dayvariations notonlyin theshort term but visit-to-visitBPV. by-day systolic home BPV is associated alsoovermoreprolongedperiodsoftime Assessment of day-by-day BPV. In the with an increased risk of a composite of (i. e. , day-by-day, visit-to-visit, orseasonal timelineofBPV, day-by-dayBPVfindsits cardiac and stroke mortality, but only BPvariations). Althoughtheselong-term position somewhere between short-term withasignificantriskofstrokemortality, blood pressure variations have been shown to be a BPV (i. e. , within the 24 h) and visit-towhen the components of the main end reproducibleandnotarandomphenomvisit BPV (i. e. , within weeks, months, or point were independently considered enon(115), evidenceislimitedaboutthe years). Measuresofthisparticulartypeof (121). More recently, evidence on the factors responsible for blood pressure changes beBPV can be obtained by means of ABPM prognostic value of day-by-day home tween visits spaced by weeks, months, performed over consecutive days (i. e. , BPV was provided in a cohort of adults oryearsinobservationalstudiesandclinover 48 h) or, more easily, by means of fromthegeneralpopulationintheframe ical trials (116118). Long-term BPV homeBPmeasurementsperformedbypaof the Finn-Home Study (122) showing mightnotentirelyconsistofspontaneous tientsoversubsequentdaysinfairlystanincreasing levels of day-by-day home blood pressure variations or reflect the same physiodardized conditions. Although HBPM BPV to be associated with a higher risk logical CV control mechanisms of shortmay not provide the same extensive inofCVeventsevenafteradjustmentsfor term blood pressure fluctuations, but it may also be formation on 24-h blood pressure patterns as ABPM ageandmeanhomeBPlevel. TheprogtheresultofimperfectstabilityofBPcon- does, it may provide information on blood pressure nostic role of day-by-day BPV is also trolintreatedsubjects(inparticular, visitchanges over a longer but still relatively supported by the demonstration by to-visit blood pressure variations during follow-up), short time (several days), when both Matsui et al. (120) that the maximum or additionally, it might reflect the subjects physiological characteristics value of HBP over a given monitoring averagescoreaccountingforboththepresenceandextentoftarget-organdamage. Thescorerangedineachpatientfrom0(eithernoclinicalevents orelectrocardiogram, chestradiograph, fundus, orrenalfunctionalterations)to3(majoralterationsontheelectrocardiogram, chestradiograph, or fundusplusaclinicalevent, renalabnormality, orboth). Foranylevelof24-hmeanintra-arterialBP, patientsinwhom24-hBPVwaslowhad alowerprevalenceandseverityoftarget-organdamagethanthoseinwhom24-hBPVwashigh. B: Rateandseverityoftarget-organdamageandleft ventricularmassindex(LVMI)inthesamepatientsasinAafter7. 4yearsoffollow-up. Patientsweredividedintoquartilesofincreasing24-hmean intra-arterialBP. Patientsineachgroupwerefurtherclassifiedintotwocategoriesaccordingtowhetherthebetween-half-hourSDofmeanintraarterialBPwasbeloworabovetheaveragevariabilityofthegroup. Withineachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBP values. Foreachclass, theseverityoftarget-organdamagewasexpressedastheaveragescore, asassessedinAwiththeadditionofechocardiographicdata. BPV(between-half-hour SDof24-h meanintra-arterialBP)attheinitialevaluationwasasignificantpredictoroftarget-organ damageatfollow-up, indicatingthatthecardiovascularcomplicationsofhypertensionmightdependonthedegreeof24-hBPV. Modifiedwith permissionfromParatietal. (66)(A)andFrattolaetal. (92)(B). care. diabetesjournals.",
    "word_count": 590,
    "char_count": 6011,
    "sentence_count": 39,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 5,
      "total_chunks": 16,
      "position": "6/16",
      "content_type": "evidence",
      "content_type_confidence": 4,
      "medical_entities": [
        "creatinine",
        "antihypertensive",
        "blood pressure control",
        "monitoring"
      ],
      "entity_count": 4
    }
  },
  {
    "chunk_id": 6,
    "text": "Patientsweredividedintoquartilesofincreasing24-hmean intra-arterialBP. Patientsineachgroupwerefurtherclassifiedintotwocategoriesaccordingtowhetherthebetween-half-hourSDofmeanintraarterialBPwasbeloworabovetheaveragevariabilityofthegroup. Withineachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBP values. Foreachclass, theseverityoftarget-organdamagewasexpressedastheaveragescore, asassessedinAwiththeadditionofechocardiographicdata. BPV(between-half-hour SDof24-h meanintra-arterialBP)attheinitialevaluationwasasignificantpredictoroftarget-organ damageatfollow-up, indicatingthatthecardiovascularcomplicationsofhypertensionmightdependonthedegreeof24-hBPV. Modifiedwith permissionfromParatietal. (66)(A)andFrattolaetal. (92)(B). care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S317 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome time is a significant predictor of events incidenceofcardiac(i. e. , diastolicdysfuncstroke, showedasteepreductionastheperin a population of elderly hypertensive tion)(127), macrovascular(i. e. , increased centageofon-treatmentvisitswithBPconpatients. intima-media thickness and stiffness) trolled(i. e. , blood pressure, 140/90mmHg)increased The prognostic role of day-by-day (128), microvascular (i. e. , development throughoutthetreatmentperiodindepenhome-measuredBPVinpredictingdevelof microand macroalbuminuria and redently of the achieved control of mean opment/progression of nephropathy in nal vascular atherosclerosis) (129, 130), clinicBP(118)(Fig. 4). type 2 diabetic patients has also been and cerebral (i. e. , white matter hyperinThe prognostic relevance of visit-toexploredinseveralstudies(123, 124). Ina tensity volume and presence of brain invisitBPVshowninthesestudiessupports large cohort of Japanese subjects with farctions) (131) organ damage as well as the recommendation of avoiding incontype2diabetes, increasingvaluesofdaywithendothelialdysfunction(132). sistentBPcontrolandlargeBPdifferences by-dayvariabilityinhomesystolicBP(asLongitudinal studies and post hoc from one visit to another, not only by a sessedthroughthecoefficientofvariation analyses of clinical trials in hypertension proper dosing/titration of antihypertenof blood pressure measures performed over 14 conhave found increasing values of intrasive treatment, but also by improving secutive days) were positively correlated individualvisit-to-visitvariabilityinconpatients adherence to treatment. Howwith urinary albumin excretion (UAE) ventionalofficeorABP(asassessedbythe ever, while in treated hypertensive and associated with an increased risk of SD or the coefficient of variation of the patients at High CV risk an increased macroalbuminuria(UAE300mgzg 21 averagein-treatmentBP)tobepredictive visit-to-visit BPV may be prognostically Creatinine). Remarkably, afteradjustment of cerebrovascular (116, 133135) and relevant(asshownintheINVESTstudy), for common confounders and mean blood pressure coronary fatal and nonfatal events (134 inmildlytomoderatelytreatedhypertenlevels, CVsofmorningSBP, morningDBP, 137) and of all-cause mortality (117) insivepatients, BPVbetweenvisitshasbeen and evening SBP remained independent dependentlyofmeanofficeorABPvalues. showntomakelittleornocontributionto predictors for UAE and were associated In some analyses, the predictive value of CV risk prediction over mean blood pressure levels withasignificantriskformacroalbuminuria intraindividualvisit-to-visitBPVhasbeen (125). of 1. 35 (P, 0. 05), 1. 29 (P, 0. 05), and showntobeevenhigherthanthatofavA post hoc analysis of the Diabetes 1. 44(P, 0. 05), respectively. erage blood pressure during treatment, suggesting ControlandComplicationsTrial(DCCT) Assessment of visit-to-visit BPV. In thattheprotectiveeffectofantihyperteninvestigatedwhethermeanBPvaluesand clinical practice, obtaining blood pressure measuresive treatment depends not only on the annual visit-to-visit BPV (as assessed ments over a consistent number of visits magnitude of the achieved mean blood pressure rethrough SD of SBP and DBP) might intoachieveameaningfulestimateofvisit- duction but also on the consistency of fluencethedevelopmentofmicrovascular to-visitBPVisusuallydifficult. Moreover, BPreduction(i. e. , thestabilityoftheoncomplications in initially normotensive OBP readings obtained in the clinic may treatmentBPcontroloverthelongterm). type 1 diabetic patients. Overall, mean not provide information on blood pressure during Thishasbeensupportedbyresultsofthe SBP and SD of SBP were related to an subjects usual activities and over a long International Verapamil-Trandolapril increased risk of development/progresperiod of time, being thus unable to (INVEST) Study conducted in a hysion of nephropathy with an odds ratio offer a representative evaluation of papertensive population at High CV risk foralbuminuriaof1. 005(95%CI1. 002 tients actual blood pressure burden. OBP is thus an (i. e. , allofwhomhadahistoryofcoronary 1. 008, P, 0. 001) and 1. 093 (1. 069 imperfectindicatorofBPcontrolandisfar disease). Inthisstudy, theincidenceoffatal 1. 117, P, 0. 001), respectively, foreach frombeinganidealmeanstoassessvisitandnonfatalCVevents, butinparticularof 1mmHgchange. Visit-to-visitvariability to-visit BPV. On the other hand, it has been shown that in treated hypertensive patientsthereproducibilityof24-hABPis clearly higher than that of isolated OBP readings(125). Thisisinpartduetothe fact that OBP can be altered by several environmentalstimuliandbythealertreactiongeneratedbythedoctorsornurses visit, whichhavenoeffecton24-hmean BPvalues. However, despite the relevant and extensive information on blood pressure levels within the 24 h provided by ABPM, it can neither be repeated frequently nor routinely applied to assess visit-to-visit BPV. Although measures performed by patients at home using HBPM may not provideinformationon24-hBPprofiles, theyseemtobeanappropriatealternative approachfortheassessmentoflong-term BPV(126).",
    "word_count": 596,
    "char_count": 6004,
    "sentence_count": 46,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 6,
      "total_chunks": 16,
      "position": "7/16",
      "content_type": "evidence",
      "content_type_confidence": 4,
      "medical_entities": [
        "nephropathy",
        "creatinine",
        "adherence"
      ],
      "entity_count": 3
    }
  },
  {
    "chunk_id": 7,
    "text": "Although measures performed by patients at home using HBPM may not provideinformationon24-hBPprofiles, theyseemtobeanappropriatealternative approachfortheassessmentoflong-term BPV(126). Figure 4dHazard ratio (heart rate) of myocardial infarction (myocardial infarction) or stroke according to the perPrognostic relevance of visit-to-visit centageofvisitswithBP, 140/90mmHg. Thegroupinwhichthisoccurredin, 25%ofthevisits BPV. Recentstudieshaveshownincreaswastakenasreference. Datawereadjustedfordifferencesinbaselinedemographicdata, blood pressure, and ing values of visit-to-visit BPV to be CVriskfactorsaswellasforin-treatmentaverageBP. ReprintedwithpermissionfromMancia associated with a higher prevalence and etal. (118). S318 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates inSBPremainedasignificantpredictorof diabetic subjects have shown that treatachievedbytreatmentbutnottoon-treatalbuminuria even after adjustment for mentwithlong-actingcalciumantagonist ment visit-to-visit clinic or 24-h BPV meanBPlevels, independentlyaddingto (i. e. , lacidipine) is effective in reducing (146). Meta-analysesextendedtoalarger mean blood pressure in predicting the risk of nenotonlymeanABPvaluesduringthe24 number of trials using the post hoc apphropathy(129). h, daytime, andnighttimebutalsothereproach showed that differences between Evidence has also been provided in spectiveBPVsexpressedasSDandcoefficlasses ofantihypertensivedrugsintheir type2diabeticpatientsthatanincreasein cient of variation. Interestingly, reductions effectivenessinpreventingstrokedespite BPV may add to mean blood pressure values in in BPV in these studies were accompanied noorlittledifferenceinmeanBPmightbe predicting outcome as shown in a large byanimprovementofbaroreflexsensitivity, duetodifferentialclasseffectsoninterincohortoftype2diabeticpatientsinwhom suggesting a plausible mechanism for the dividual BPV (i. e. , between-patient disblood pressure levels were measured at every visit effectsofantihypertensivetreatmentinstapersion of mean blood pressure values during over a year. Increasing values of visit-tobilizingBPvariation(144). treatment)(147). However, amajorlimivisit systolic BPV (as assessed through More recently, a study in type 2 tation of interindividual BPV (or group coefficientofvariation)weredirectlycordiabetic patients explored whether treatBPV)is thatitrepresents the effect ofBP related with UAE and with arterial stiffment with an angiotensin II type 1 retreatmentinagroupofpatientsandcan- ness (assessed through pulse wave ceptorblockercouldimproveambulatory notaccuratelyreflectvariationsinBPvalvelocity) and inversely correlated with short-term BPV in hypertensive patients ues from visit to visit in individual ankle-brachial index (an indirect marker with diabetic nephropathy. After 12 subjects. Based on the prognostic releofatherosclerosis)(138). weeks of treatment, 24-h, daytime, and vanceofvisit-to-visitBPV, onecouldinfer nighttime short-term BPV (as assessed thatconsistencyofBPcontrolrepresents Potential implications of short-term through calculation of the coefficient of an additional important goal of antihyBPV for hypertension management variation) was significantly decreased by pertensive treatment (118). However, it Although it has been suggested that in treatment. Interestingly, thesereductions shouldbeconsideredthatmostevidence order to optimize CV protection in hyin BPV were accompanied by significant on visit-to-visit BPV in relation to propertensive patients, antihypertensive reductions in urinary Protein excretion, gression of organ damage or incidence treatmentshouldbetargetedatstabilizing brachial-ankle pulse wave velocity, and of CV events has been obtained from BPV in addition to reducing absolute blood pressure indicesofautonomicCVmodulation(i. e. , post hoc analyses of trial data and based values, most controlled trials using difLow frequencytoHigh frequency ratio, oncomparisonsbetweennonrandomized ferentantihypertensivedrugclassesasan anindexofsympathovagalbalance)suggroups, which may have introduced a active regimen have strongly supported gestingpotentialmechanismsforthebenlarge number of potential confounders, the preponderant role of mean blood pressure reeficial effects of angiotensin receptor thusunderminingthestudyconclusions. duction in achieving CV protection (7). blockadeondiabeticnephropathy(145). Atpresent, theonlyevidencethatmodConclusions ulation of 24-h BPV with antihypertenPotential implications of long-term Evidence from observational and intersivetreatmentmaybebeneficialinterms BPV for hypertension management ventional studies has indicated that the of CV protection comes from studies When it comes to reducing BPV in the riskofCVmorbidityandmortalityhasa making use of the smoothness index long term, recent post hoc analyses perstrong and continuous relationship with (i. e. , the ratio between the average of formed on the basis of the data of the meanBPlevels(3, 4)andthatloweringBP the24-hBPchangesinducedbyagiven Anglo-Scandinavian Cardiac Outcome levels confers significant CV protection medication and its SD) in assessing the Trial(ASCOT)andtheMedicalResearch regardless of the drug class used distribution of blood pressure reduction by treatCouncil Trial of Treatment of Hyperten- (7, 148). Out-of-officeBPlevelsmeasured ment (67, 139).",
    "word_count": 574,
    "char_count": 5434,
    "sentence_count": 25,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 7,
      "total_chunks": 16,
      "position": "8/16",
      "content_type": "evidence",
      "content_type_confidence": 6,
      "medical_entities": [
        "nephropathy",
        "antihypertensive"
      ],
      "entity_count": 2
    }
  },
  {
    "chunk_id": 8,
    "text": "Out-of-officeBPlevelsmeasured ment (67, 139). This index has been sioninOlderAdults(MRC-elderly)have either with ABPM or with HBPM have showntoberelatedtodrug-inducedrereportedthatintraindividualvisit-to-visit been shown to be even better predictors gression of target-organ damage at carBPV(i. e. , variabilityofanindividualsBP ofoutcomescomparedwithOBPandmay diac level (i. e. , left ventricular mass from visit to visit) may be differentially also allow identification of masked index) (67) as well as to drug-induced affected by antihypertensive drug classes hypertension, a condition that needs to reductionintheprogressionofchanges and that these differences might explain beproperlytreated, asitbearsanadverse incarotidarterywallthickness, partially the variable effects of blood pressure-lowering drugs CVprognosissimilartothatofsustained independent of basal mean blood pressure values in preventing outcome, with calcium hypertension. ABPM in diabetic subjects (139). channelblockerscoringbest(134). Howmaybeapowerfultoolforabetterstrat- Evidenceisavailablethatsomeclasses ever, contrasting results were observed ificationoftheCVriskrelatedtoelevated oforalantidiabetesdrugs(i. e. , thiazolidiin a post hoc analysis of the European blood pressure, whichinturnisasubstantialcontribnediones), maynotonlyhaveabeneficial Lacidipine Study on Atherosclerosis utortoCVmorbidityandmortalityindieffecton24-hBPlevelsbutalsoimprove (ELSA), in mild-to-moderate hypertenabetes. Moreover, ABPM may also be day-night blood pressure profile in diabetic subjects sivepatients, wherenosubstantialdifferhelpful in detecting alterations in auto- (140, 141). Althoughseveralstudiesindiencesbetweenab-blockerandacalcium nomiccontroloftheCVsystem, reflected abeticpatientshaveshowntheefficacyof antagonist in relation to intraindividual bytheabsenceofnocturnalBPfallorbya differentantihypertensivedrugclassesin visit-to-visitBPVwereobserved(125). Inreduced24-hheartratevariabilityandan controlling blood pressure levels over the 24 h deed, whenthepooleddataofthisstudy increased 24-h BPV. Despite the large (142, 143), nosignificantimpactondaywere analyzed, carotid intima-media bodyofevidencesupportingthepreponnightBPprofileshasbeenevidentinthese thicknessandCVoutcomeswererelated derantroleofaverageBPvaluesindeterstudies. However, somestudiesintype2 to the mean clinic or ambulatory SBP mining the CV risk associated with High care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S319 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome BPlevels, theextentoffluctuationsofBP ArterialHypertension: TheTaskForcefor 12. CollinsR, MacMahonS. Bloodpressure, over time may provide additional, indetheManagementofArterialHypertension antihypertensivedrugtreatmentandthe pendent prognostic information. EvioftheEuropeanSocietyofHypertension risks of stroke and of coronary Heart dence supporting this concept has been (ESH) and of the European Society of disease. BrMedBull1994; 50: 272298 Cardiology (ESC). J Hypertens 2007; 25: 13. Holman respiratory rate, Paul SK, Bethel MA, Neil providedbyseveralstudiesshowingthat 11051187 HA, MatthewsDR. Long-termfollow-up notonlyelevationinaverageBPlevelsbut 2. EzzatiM, LopezAD, RodgersA, Vander after tight control of Blood Hypertension in alsoanincreasedBPV(eitherintheshort Hoorn S, MurrayCJ; ComparativeRisk type2diabetes. NEnglJMed2008; 359: term or in the long term) may indepenAssessment Collaborating Group. Se15651576 dentlyaddtoCVriskpredictionoverand lectedmajorriskfactorsandglobaland 14. Holman respiratory rate, Paul SK, Bethel MA, above the contribution of elevated mean regionalburdenofdisease. Lancet2002; MatthewsDR, NeilHA. 10-yearfollowBPlevels. Althoughithasbeensuggested 360: 13471360 upofintensiveglucosecontrolintype2 that in order to achieve the highest CV 3. MacMahon S, Peto R, Cutler J, et al. Diabetes. NEnglJMed2008; 359: 1577 protection in hypertensive patients antiBlood Hypertension, stroke, and coronary 1589 hypertensive treatment should betargetHeart disease. Part 1, Prolonged differ15. Gaede P, Lund-Andersen H, Parving ences in Blood Hypertension: prospective HH, PedersenO. Effectofamultifactoedatnormalizing24-hBPVinadditionto observational studies corrected for the rial intervention on mortality in type 2 reducing absolute 24-h blood pressure levels, eviregression dilution bias. Lancet 1990; Diabetes. N Engl J Med 2008; 358: 580 denceisstilllimitedregardingthetargets 335: 765774 591 of BPV to achieve with antihypertensive 4. LewingtonS, ClarkeR, QizilbashN, Peto 16. UKProspectiveDiabetesStudy(UKPDS) treatment. Because 24-h ABPM has not R, Collins R; Prospective Studies ColGroup. Intensive Blood-glucose control been routinely used in large-scale trials laboration. Age-specific relevance of with sulphonylureas or insulin comon antihypertensive treatment, the prousual Blood Hypertension to vascular morpared with conventional treatment and tective effect of treatment-induced tality: ameta-analysisofindividualdata risk of complications in patients with changes in 24-h BPV with respect to the foronemillionadultsin61prospective type 2 Diabetes (UKPDS 33). Lancet concomitant changes in mean blood pressure levels studies. Lancet2002; 360: 19031913 1998; 352: 837853 5. Haffner SM, Lehto S, Rnnemaa T, 17. HanssonL, ZanchettiA, CarruthersSG, still needs to be properly documented. Pyrl potassium, Laakso M. Mortality from et al. ; HOT Study Group.",
    "word_count": 570,
    "char_count": 5479,
    "sentence_count": 45,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 8,
      "total_chunks": 16,
      "position": "9/16",
      "content_type": "evidence",
      "content_type_confidence": 6,
      "medical_entities": [
        "potassium",
        "calcium",
        "insulin",
        "antihypertensive"
      ],
      "entity_count": 4
    }
  },
  {
    "chunk_id": 9,
    "text": "Pyrl potassium, Laakso M. Mortality from et al. ; HOT Study Group. Effects of inWhenitcomesto long-term BPV, recent coronary Heart disease in subjects with tensive Blood-Hypertension lowering and meta-analyses of clinical trials on hypertype2diabetesandinnondiabeticsub- Low-dose aspirin in patients with hytensionhaveshownanincreasedvisit-tojectswithandwithoutpriormyocardial pertension: principal results of the HyvisitBPVorlackofBPcontrolatanygiven infarction. NEnglJMed1998; 339: 229 pertension Optimal Treatment (HOT) visittobeassociatedwithanadverseCV 234 randomised trial. Lancet 1998; 351: prognosis. These data suggest that 6. Kannel WB, McGee DL. Diabetes and 17551762 smoothing control of blood pressure levels not only cardiovasculardisease. TheFramingham 18. UK Prospective Diabetes Study Group. throughoutthe24hbutalsointhelongstudy. JAMA1979; 241: 20352038 Tightbloodpressurecontrolandriskof term follow-up of hypertensive patients 7. Turnbull F; Blood Hypertension Lowering macrovascular and microvascular commaybeimportantforoptimizingCVpro- Treatment Trialists Collaboration. Efplicationsintype2diabetes: UKPDS38. fects of different Blood-Hypertension-lowerBMJ1998; 317: 703713 tection. However, before being recoming regimens on major cardiovascular 19. Estacio RO, Jeffers BW, Hiatt WR, mended as a target for antihypertensive events: resultsofprospectively-designed Biggerstaff SL, Gifford N, Schrier RW. treatmentindailyclinicalpractice, further overviews of randomised trials. Lancet The effect of nisoldipine as compared prospective outcome studies should be 2003; 362: 15271535 with enalapril on cardiovascular outconducted to support that a treatment8. HypertensioninDiabetesStudy(HDS). comes in patients with non-insulininducedreductioninBPVisaccompanied HypertensioninDiabetesStudy(HDS): dependentdiabetesandhypertension. N byacorresponding reductioninCVrisk II. Increased risk of cardiovascular EnglJMed1998; 338: 645652 over and above that already achieved by complications in hypertensive type 2 20. PatelA, MacMahonS, ChalmersJ, etal. ; reducingmeanBPlevels. diabetic patients. J Hypertens 1993; 11: ADVANCECollaborativeGroup. Effects 319325 of a fixed combination of perindopril 9. TurnerRC, MillnsH, NeilHA, etal. Risk and indapamide on macrovascular and AcknowledgmentsdNopotentialconflictsof factors for coronary artery disease in microvascularoutcomesinpatientswith non-insulin dependent Diabetes mellitype2diabetesmellitus(theADVANCE interestrelevanttothisarticlewerereported. tus: United Kingdom Prospective Ditrial): a randomised controlled trial. G. P. , J. E. O. , P. S. , C. L. , andG. B. performed abetes Study (UKPDS: 23). BMJ 1998; Lancet2007; 370: 829840 researchandwrote, reviewed, andeditedthe 316: 823828 21. Heart Outcomes Prevention Evaluation manuscript. G. P. istheguarantorofthiswork 10. HypertensioninDiabetesStudy(HDS). Study Investigators. Effects of ramipril and, assuch, hadfullaccesstoallthedatain HypertensioninDiabetesStudy(HDS): on cardiovascular and microvascular the study and takes responsibility for the inI. Prevalence of hypertension in newly outcomes in people with Diabetes meltegrityofthedataandtheaccuracyofthedata presenting type 2 diabetic patients and litus: results of the HOPE study and analysis. theassociationwithriskfactorsforcarMICRO-HOPE substudy. Lancet 2000; diovascularanddiabeticcomplications. J 355: 253259 Hypertens1993; 11: 309317 22. TuomilehtoJ, RastenyteD, Birkenhger References 11. Adler AI, Stratton IM, Neil HA, et al. WH, et al. ; Systolic Hypertension in 1. Mancia G, De Backer G, Dominiczak A, Association of systolic Blood Hypertension Europe Trial Investigators. Effects of etal. ; Management ofArterialHypertenwith macrovascular and microvascular calcium-channel blockade in older pasion of the European Society of Hypercomplicationsoftype2diabetes(UKPDS tients with Diabetes and systolic hytension; EuropeanSocietyofCardiology. 36): prospective observational study. pertension. N Engl J Med 1999; 340: 2007 Guidelines for the Management of BMJ2000; 321: 412419 677684 S320 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates 23. BakrisGL, GaxiolaE, MesserliFH, etal. ; 35. Fagard RH, Staessen JA, Thijs L. Repredictors of death and cause-specific INVEST Investigators. Clinical outlationships between changes in left cardiovascular events in hypertension. comes in the Diabetes cohort of the ventricular mass and in clinic and amHypertension2008; 51: 5561 INternationalVErapamilSR-Trandolapril bulatory Blood Hypertension in response to 47. BoggiaJ, LiY, ThijsL, etal. ; International study. Hypertension2004; 44: 637642 antihypertensive therapy. J Hypertens DatabaseonAmbulatorybloodpressure 24. Staessen JA, Thijs L, Fagard R, et al. ; 1997; 15: 14931502 monitoringinrelationtoCardiovascular Systolic Hypertension in Europe Trial 36. ManciaG, ZanchettiA, Agabiti-RoseiE, Outcomes(IDACO)investigators. ProgInvestigators. Predicting cardiovascular et al. ; SAMPLE Study Group. Study on nosticaccuracyofdayversusnightamrisk using conventional vs ambulatory Ambulatory Monitoring of Blood Presbulatorybloodpressure: acohortstudy. Blood Hypertension in older patients with sure and Lisinopril Evaluation. AmbuLancet2007; 370: 12191229 systolic hypertension.",
    "word_count": 598,
    "char_count": 5351,
    "sentence_count": 73,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 9,
      "total_chunks": 16,
      "position": "10/16",
      "content_type": "evidence",
      "content_type_confidence": 5,
      "medical_entities": [
        "potassium",
        "calcium",
        "insulin",
        "antihypertensive",
        "monitoring"
      ],
      "entity_count": 5
    }
  },
  {
    "chunk_id": 10,
    "text": "Blood Hypertension in older patients with sure and Lisinopril Evaluation. AmbuLancet2007; 370: 12191229 systolic hypertension. JAMA 1999; 282: latorybloodpressureissuperiortoclinic 48. Bauduceau B, Gens N, Chamontin B, 539546 bloodpressureinpredictingtreatmentet al. Ambulatory Blood Hypertension and 25. Sega R, Facchetti R, Bombelli M, et al. induced regression of left ventricular urinary albumin excretion in diabetic Prognostic value of ambulatory and hypertrophy. Circulation1997; 95: 1464 (non-insulin-dependent and insulinhome Blood pressures compared with 1470 dependent) hypertensive patients: relaoffice Blood Hypertension in the general 37. Fagard RH, Staessen JA, Thijs L. Pretionshipsatbaselineandaftertreatment population: follow-up results from the dictionofcardiacstructureandfunction by the angiotensin converting enzyme Pressioni Arteriose Monitorate e Loro byrepeatedclinicandambulatoryblood inhibitor trandolapril. Am J Hypertens Associazioni (PAMELA) study. CirculaHypertension. Hypertension1997; 29: 2229 1998; 11: 10651073 tion2005; 111: 17771783 38. Verdecchia P, Schillaci G, Guerrieri M, 49. daCostaRodriguesT, PecisM, Azevedo 26. KikuyaM, OhkuboT, AsayamaK, etal. etal. Circadian bloodpressurechanges MJ, Esteves JF, Gross JL. Ambulatory Ambulatorybloodpressureand10-year and left ventricular hypertrophy in esBlood Hypertension monitoring and prorisk of cardiovascular and noncardiosential hypertension. Circulation 1990; gressionofretinopathyinnormotensive, vascular mortality: the Ohasama study. 81: 528536 normoalbuminuric type 1 diabetic paHypertension2005; 45: 240245 39. Mancia G, Omboni S, Parati G, et al. tients: a6-yearfollow-upstudy. Diabetes 27. Fagard RH, Celis H. Prognostic signifiTwenty-four hour ambulatory Blood ResClinPract2006; 74: 135140 canceofvariouscharacteristicsofout-ofHypertension in the Hypertension Optimal 50. EguchiK, PickeringTG, HoshideS, etal. the-office Blood Hypertension. J Hypertens Treatment (HOT) study. J Hypertens Ambulatory Blood Hypertension is a better 2004; 22: 16631666 2001; 19: 17551763 marker than clinic Blood Hypertension in 28. Hansen TW, Li Y, Boggia J, Thijs L, 40. ClementDL, DeBuyzereML, DeBacquer predicting cardiovascular events in paRichartT, StaessenJA. Predictiveroleof DA, et al. ; Office versus Ambulatory tientswith/withouttype2diabetes. AmJ the nighttime Blood Hypertension. HyperPressureStudyInvestigators. Prognostic Hypertens2008; 21: 443450 tension2011; 57: 310 value of ambulatory Blood-Hypertension re51. Verdecchia P, Reboldi G, Porcellati C, 29. Parati G, Stergiou GS, Asmar R, et al. ; cordings in patients with treated hyet al. Risk of cardiovascular disease in ESHWorkingGrouponBloodPressure pertension. N Engl J Med 2003; 348: relation to achieved office and ambulaMonitoring. European Society of Hy24072415 tory Blood Hypertension control in treated pertensionguidelinesforbloodpressure 41. FagardRH, VanDenBroekeC, DeCort hypertensivesubjects. JAmCollCardiol monitoring at home: a summaryreport P. Prognostic significance of Blood 2002; 39: 878885 of the Second International Consensus pressuremeasuredintheoffice, athome 52. Dolan E, Stanton AV, Thom S, et al. ; Conference on Home Blood Hypertension and during ambulatory monitoring in ASCOTInvestigators. Ambulatoryblood Monitoring. JHypertens2008; 26: 1505 olderpatientsingeneralpractice. JHum pressuremonitoringpredictscardiovas1526 Hypertens2005; 19: 801807 cular events in treated hypertensive 30. Parati G, Mancia G. White coat effect: 42. Redon J, Campos C, Narciso ML, patientsdanAnglo-Scandinaviancardiac semantics, assessment and pathophysiRodicio JL, Pascual JM, Ruilope LM. outcomes trial substudy. J Hypertens ologicalimplications. JHypertens2003; Prognostic value of ambulatory Blood 2009; 27: 876885 21: 481486 Hypertension monitoring in refractory hy53. Mancia G, Facchetti R, Bombelli M, 31. Pickering TG, Davidson potassium, Gerin W, pertension: aprospectivestudy. HyperGrassi G, Sega R. Long-term risk of SchwartzJE. Maskedhypertension. Hytension1998; 31: 712718 mortality associated with selective and pertension2002; 40: 795796 43. Imai Y, Ohkubo T, Sakuma M, et al. combinedelevationinoffice, home, and 32. ParatiG, UlianL, SantucciuC, Omboni Predictive power of screening Blood ambulatory Blood Hypertension. HypertenS, Mancia G. Difference between clinic Hypertension, ambulatory Blood Hypertension sion2006; 47: 846853 and daytime Blood Hypertension is not a and Blood Hypertension measured at home 54. OhkuboT, ImaiY, TsujiI, etal. Home measure of the white coat effect. Hyforoverallandcardiovascularmortality: Blood Hypertension measurement has a pertension1998; 31: 11851189 a prospective observation in a cohort stronger predictive power for mortality 33. ChobanianAV, BakrisGL, BlackHR, etal. ; from Ohasama, northern Japan. Blood than does screening Blood Hypertension JointNationalCommitteeonPrevention, PressMonit1996; 1: 251254 measurement: a population-based obDetection, Evaluation, and Treatment of 44.",
    "word_count": 598,
    "char_count": 5002,
    "sentence_count": 67,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 10,
      "total_chunks": 16,
      "position": "11/16",
      "content_type": "monitoring",
      "content_type_confidence": 5,
      "medical_entities": [
        "potassium",
        "insulin",
        "cardiovascular disease",
        "screening",
        "monitoring"
      ],
      "entity_count": 5
    }
  },
  {
    "chunk_id": 11,
    "text": "Blood than does screening Blood Hypertension JointNationalCommitteeonPrevention, PressMonit1996; 1: 251254 measurement: a population-based obDetection, Evaluation, and Treatment of 44. DolanE, StantonA, ThijsL, etal. Supeservation in Ohasama, Japan. J HyperHypertension. National Heart, riority of ambulatory over clinic Blood tens1998; 16: 971975 Lung, andBloodInstitute; NationalHigh Hypertension measurement in predicting 55. Hozawa A, Ohkubo T, Nagai potassium, et al. Blood Hypertension Education Program Comortality: the Dublin outcome study. Prognosis of isolated systolic and isoordinatingCommittee. Seventhreportof Hypertension2005; 46: 156161 lated diastolic hypertension as assessed the Joint National Committee on Pre45. Hansen TW, Jeppesen J, Rasmussen S, by self-measurement of Blood Hypertension vention, Detection, Evaluation, and Ibsen H, Torp-PedersenC. Ambulatory at home: the Ohasama study. Arch InTreatmentofHighBloodPressure. Hybloodpressureandmortality: apopulationternMed2000; 160: 33013306 pertension2003; 42: 12061252 basedstudy. Hypertension2005; 45: 499 56. OhkuboT, AsayamaK, KikuyaM, etal. ; 34. Parati G, Pickering TG. Home Blood504 Ohasama Study. How many times Hypertension monitoring: ultrasound and European 46. FagardRH, CelisH, ThijsL, etal. Dayshould Blood Hypertension be measured at consensus. Lancet2009; 373: 876878 time and nighttime Blood Hypertension as homeforbetterpredictionofstrokerisk? care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S321 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome Ten-year follow-up results from the in hypertension research and clinical spontaneous baroreflex sensitivity proOhasama study. J Hypertens 2004; 22: practice. Hypertension 1993; 21: 510 vide early detection of autonomic dys10991104 524 functionindiabetesmellitus. Diabetologia 57. AsayamaK, OhkuboT, KikuyaM, etal. 69. BiloG, GiglioA, StyczkiewiczK, etal. A 1997; 40: 14701475 Use of 2003 European Society of Hynew method for assessing 24-h Blood 82. TamuraK, TsurumiY, SakaiM, etal. A pertension-European Society of CardiHypertension variability after excluding the possiblerelationshipofnocturnalblood ology guidelines for predicting stroke contributionofnocturnalbloodpressure pressurevariabilitywithcoronaryartery using self-measured Blood Hypertension at fall. JHypertens2007; 25: 20582066 disease in diabetic nephropathy. Clin home: the Ohasama study. Eur Heart J 70. MenaL, PintosS, QueipoNV, Aizprua ExpHypertens2007; 29: 3142 2005; 26: 20262031 JA, Maestre G, Sulbar(cid: 1)an T. A reliable 83. FogariR, ZoppiA, MalamaniGD, Lazzari 58. Nishinaga M, Takata J, Okumiya potassium, index for the prognostic significance of P, Destro M, Corradi L. Ambulatory MatsubayashiK, OzawaT, DoiY. Hypertension variability. J Hypertens Blood Hypertension monitoring in normomorning home Blood Hypertension is asso2005; 23: 505511 tensiveandhypertensivetype2diabetes. ciated with a loss of functional in71. ManciaG, BombelliM, FacchettiR, etal. Prevalence of impaired diurnal Blood dependenceinthecommunity-dwelling Long-term prognostic value of Blood pressurepatterns. AmJHypertens1993; elderlyaged75yearsorolder. Hypertens Hypertension variability in the general pop6: 17 Res2005; 28: 65766 ulation: resultsofthePressioniArteriose 84. UedaY, AoiW, YamachikaS, NagatakiS. 59. Okumiya potassium, Matsubayashi potassium, Wada T, Monitorate e Loro Associazioni Study. Lossofnocturnaldeclineinbloodpreset al. A U-shaped association between Hypertension2007; 49: 12651270 sureindiabeticpatientswithautonomic home systolicbloodpressureand four72. Stolarz-Skrzypek potassium, Thijs L, Richart T, neuropathy. Jpn Heart J 1992; 33: 801 year mortality in community-dwelling et al. Blood Hypertension variability in re815 older men. J Am Geriatr Soc 1999; 47: lation to outcome in the International 85. Spallone V, Maiello MR, Morganti R, 14151421 DatabaseofAmbulatoryBloodPressure Mandica S, Frajese G. Usefulness of 60. Agarwal R, Andersen MJ. Prognostic in relation to cardiovascular outcome. ambulatory Blood Hypertension monitoring importance of clinic and home Blood HypertensRes2010; 33: 757766 inpredictingthepresenceofautonomic Hypertension recordings in patients with 73. Mancia G, Parati G, Pomidossi G, neuropathyintypeIdiabeticpatients. J chronickidneydisease. KidneyInt2006; Casadei R, Di Rienzo M, Zanchetti A. HumHypertens2007; 21: 381386 69: 406411 Arterialbaroreflexesandbloodpressure 86. Tasali E, Mokhlesi B, Van Cauter E. 61. AgarwalR, AndersenMJ. Bloodpressure and Heart rate variabilities in humans. Obstructive sleep apnea and type 2 direcordingswithinandoutsidetheclinic Hypertension1986; 8: 147153 abetes: interacting epidemics. Chest and cardiovascular events in chronic 74. ParatiG, SaulJP, DiRienzoM, ManciaG. 2008; 133: 496506 kidneydisease. AmJNephrol2006; 26: Spectral analysis of Blood Hypertension 87. Mancia G, Parati G, Hennig M, et al. ; 503510 andheartratevariabilityinevaluating ELSA Investigators. Relation between 62.",
    "word_count": 597,
    "char_count": 5038,
    "sentence_count": 74,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 11,
      "total_chunks": 16,
      "position": "12/16",
      "content_type": "monitoring",
      "content_type_confidence": 4,
      "medical_entities": [
        "nephropathy",
        "potassium",
        "neuropathy",
        "screening",
        "monitoring"
      ],
      "entity_count": 5
    }
  },
  {
    "chunk_id": 12,
    "text": "Mancia G, Parati G, Hennig M, et al. ; 503510 andheartratevariabilityinevaluating ELSA Investigators. Relation between 62. StergiouGS, BaibasNM, Kalogeropoulos cardiovascular regulation. A critical Blood Hypertension variability and carotid PG. Cardiovascularriskpredictionbased appraisal. Hypertension 1995; 25: 1276 arterydamageinhypertension: baseline on home Blood Hypertension measurement: 1286 data from the European Lacidipine theDidimastudy. JHypertens2007; 25: 75. ConwayJ, BoonN, DaviesC, JonesJV, Study on Atherosclerosis (ELSA). J Hy15901596 Sleight P. Neural and humoral mechapertens2001; 19: 19811989 63. Bobrie G, Chatellier G, Genes N, et al. nisms involved in Blood Hypertension vari88. Mancia G, Parati G: The role of Blood Cardiovascular prognosis of masked ability. JHypertens1984; 2: 203208 Hypertension variability in end-organ damhypertension detected by Blood pres76. Parati G, Castiglioni P, Di Rienzo M, age. J Hypertens Suppl 2003; 21: S17 sureself-measurementinelderlytreated Omboni S, Pedotti A, Mancia G. SeS23 hypertensive patients. JAMA 2004; 291: quential spectral analysis of 24-hour 89. Sega R, Corrao G, Bombelli M, et al. 13421349 Blood Hypertension and pulse interval in Blood Hypertension variability and organ 64. ParatiG, OchoaJE, BiloG. Bloodpreshumans. Hypertension 1990; 16: 414 damageinageneralpopulation: results surevariability, cardiovascularrisk, and 421 from the PAMELA study (Pressioni Arrisk for renal disease progression. Curr 77. Schillaci G, Bilo G, Pucci G, et al. ReterioseMonitorateELoroAssociazioni). HypertensRep2012; 14: 421431 lationship between short-term Blood Hypertension2002; 39: 710714 65. Mancia G, Ferrari A, Gregorini L, et al. Hypertension variability and large-artery 90. TatascioreA, RendaG, ZimarinoM, etal. Blood Hypertension and Heart rate variastiffness in human hypertension: findAwakesystolicbloodpressurevariability bilities in normotensive and hypertenings from 2 large databases. Hypertencorrelates with target-organ damage in sive human beings. Circ Res 1983; 53: sion2012; 60: 369377 hypertensive subjects. Hypertension 96104 78. BertinieriG, ParatiG, UlianL, etal. He2007; 50: 325332 66. Parati G, Pomidossi G, Albini F, modilution reduces clinic and ambula91. ManiosE, TsagalisG, TsivgoulisG, etal. MalaspinaD, ManciaG. Relationshipof tory Blood Hypertension in polycythemic Timerateofbloodpressurevariationis 24-hourbloodpressuremeanandvaripatients. Hypertension 1998; 31: 848 associatedwithimpairedrenalfunction abilitytoseverityoftarget-organdamage 853 in hypertensive patients. J Hypertens in hypertension. J Hypertens 1987; 5: 79. OzawaM, TamuraK, IwatsuboK, etal. 2009; 27: 22442248 9398 Ambulatorybloodpressurevariabilityis 92. FrattolaA, ParatiG, CuspidiC, AlbiniF, 67. ParatiG, OmboniS, RizzoniD, Agabitiincreasedindiabetichypertensives. Clin Mancia G. Prognostic value of 24-hour RoseiE, ManciaG. ThesmoothnessinExpHypertens2008; 30: 213224 Blood Hypertension variability. J Hypertens dex: a new, reproducible and clinically 80. RuizJ, MonbaronD, ParatiG, etal. Di1993; 11: 11331137 relevantmeasureofthehomogeneityof abetic neuropathy is a more important 93. Sander D, Kukla C, Klingelhfer J, the Blood Hypertension reduction with determinant of baroreflex sensitivity WinbeckK, ConradB. Relationshipbetreatmentforhypertension. JHypertens thancarotidelasticityintype2diabetes. tweencircadianbloodpressurepatterns 1998; 16: 16851691 Hypertension2005; 46: 162167 andprogressionofearlycarotidathero68. Mancia G, Di Rienzo M, Parati G. Am81. FrattolaA, ParatiG, GambaP, etal. Time sclerosis: A3-yearfollow-upstudy. Cirbulatorybloodpressuremonitoringuse and frequency domain estimates of culation2000; 102: 15361541 S322 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates 94. Kario potassium, Pickering TG, Umeda Y, et al. nocturnal decline in Blood Hypertension in 117. Muntner P, Shimbo D, Tonelli M, Morning surge in Blood Hypertension as a individualswithandwithouthigh24-h Reynolds potassium, Arnett DK, Oparil S. The predictor of silent and clinical cerebroBlood Hypertension: the Ohasama study. J relationship between visit-to-visit varivascular disease in elderly hypertenHypertens2002; 20: 21832189 ability in systolic Blood Hypertension and sives: a prospective study. Circulation 105. VerdecchiaP. Prognosticvalueofambuall-cause mortality in the general pop2003; 107: 14011406 latory bloodpressure: current evidence ulation: findings from NHANES III, 95. KarioK, IshikawaJ, PickeringTG, etal. and clinical implications. Hypertension 1988 to 1994. Hypertension 2011; 57: Morning hypertension: the strongest 2000; 35: 844851 160166 independentriskfactorforstrokeinel106. AmiciA, CicconettiP, SagrafoliC, etal. 118. ManciaG, MesserliF, BakrisG, ZhouQ, derly hypertensive patients. Hypertens Exaggerated morning Blood Hypertension ChampionA, PepineCJ. Bloodpressure Res2006; 29: 581587 surge and cardiovascular events. A control and improved cardiovascular 96.",
    "word_count": 590,
    "char_count": 5050,
    "sentence_count": 78,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 12,
      "total_chunks": 16,
      "position": "13/16",
      "content_type": "evidence",
      "content_type_confidence": 4,
      "medical_entities": [
        "potassium",
        "neuropathy"
      ],
      "entity_count": 2
    }
  },
  {
    "chunk_id": 13,
    "text": "Bloodpressure Res2006; 29: 581587 surge and cardiovascular events. A control and improved cardiovascular 96. Verdecchia P, Angeli F, Gattobigio R, 5-year longitudinal study in normotenoutcomesintheInternationalVerapamil RapicettaC, ReboldiG. Impactofblood sive and well-controlled hypertensive SR-Trandolapril Study. Hypertension pressurevariabilityoncardiacandcereelderly. ArchGerontolGeriatr2009; 49: 2007; 50: 299305 brovascular complications in hypertene105e109 119. Parati G, Bilo G. Calcium antagonist sion. AmJHypertens2007; 20: 154161 107. VerdecchiaP, AngeliF, MazzottaG, etal. added to angiotensin receptor blocker: 97. Hansen TW, Thijs L, Li Y, et al. ; InDay-night dip and early-morning surge a recipe for reducing Blood Hypertension ternational Database on Ambulatory in Blood Hypertension in hypertension: variability? Evidence from day-by-day Blood Hypertension in Relation to Cardioprognostic implications. Hypertension home Blood Hypertension monitoring. Hyvascular Outcomes Investigators. Prog2012; 60: 3442 pertension2012; 59: 10911093 nosticvalueofreading-to-readingblood 108. LurbeE, RedonJ, PascualJM, Tacons J, 120. Matsui Y, Ishikawa J, Eguchi potassium, Hypertension variability over 24 hours in Alvarez V. The spectrum of circadian ShibasakiS, ShimadaK, KarioK. Maxi8938 subjects from 11 populations. bloodpressurechangesintypeIdiabetic mum value of home Blood Hypertension: Hypertension2010; 55: 10491057 patients. JHypertens2001; 19: 14211428 anovelindicatoroftargetorgandamage 98. Dawson SL, Manktelow BN, Robinson 109. Palmas W, Pickering T, Teresi J, et al. inhypertension. Hypertension2011; 57: TG, Panerai RB, Potter JF. Which paNocturnal Blood Hypertension elevation 10871093 rameters of beat-to-beat Blood Hypertension predicts progression of albuminuria in 121. Kikuya M, Ohkubo T, Metoki H, et al. and variability best predict early outelderly people with type 2 Diabetes. J Day-by-dayvariabilityofbloodpressure comeafteracuteischemicstroke? Stroke Clin Hypertens (Greenwich) 2008; 10: and Heart rate at home as a novel pre2000; 31: 463468 1220 dictorofprognosis: theOhasamastudy. 99. PringleE, PhillipsC, ThijsL, etal. ; Syst110. Nakano S, Uchida potassium, Kigoshi T, et al. Hypertension2008; 52: 10451050 Eur investigators. Systolic Blood presCircadian rhythm of Blood Hypertension in 122. Johansson JK, Niiranen TJ, Puukka PJ, surevariabilityasariskfactorforstroke normotensive NIDDM subjects. Its reJula AM. Prognostic value of the variand cardiovascular mortality in the ellationship to microvascular complicaability in home-measured Blood presderlyhypertensivepopulation. JHypertions. DiabetesCare1991; 14: 707711 sure and Heart rate: the Finn-Home tens2003; 21: 22512257 111. Fel(cid: 1)cio JS, de Souza before meals, Kohlmann N, Study. Hypertension2012; 59: 212218 100. Stolarz-Skrzypek potassium, Thijs L, Li Y, et al. KohlmannO, Jr, RibeiroAB, ZanellaMT. 123. Tamura potassium, Azushima potassium, Umemura S. Short-termbloodpressurevariabilityin Nocturnal Blood Hypertension fall as preDay-by-dayhome-measuredbloodpresrelationtooutcomeintheInternational dictor of diabetic nephropathy in hysurevariability: anotherimportantfactor DatabaseofAmbulatorybloodpressure pertensivepatientswithtype2diabetes. inhypertensionwithdiabeticnephropin relation to Cardiovascular Outcome CardiovascDiabetol2010; 9: 36 athy? Hypertens Res 2011; 34: 1249 (IDACO). ActaCardiol2011; 66: 701706 112. Farmer CK, Goldsmith DJ, Quin JD, 1250 101. Pickering TG, Hall JE, Appel LJ, et al. ; etal. Progressionofdiabeticnephropa124. Ushigome E, Fukui M, Hamaguchi M, SubcommitteeofProfessionalandPublic thyisdiurnalbloodpressurerhythmas et al. The coefficient variation of home Education of the American Heart Assoimportant as absolute Blood Hypertension Blood Hypertension is a novel factor associciationCouncilonHighBloodPressure level? NephrolDialTransplant1998; 13: ated with macroalbuminuria in type 2 Research. Recommendations for Blood 635639 Diabetes mellitus. Hypertens Res 2011; Hypertension measurement in humans and 113. Sturrock ND, George E, Pound N, Ste34: 12711275 experimental animals: Part 1: Blood venson J, Peck GM, Sowter H. Non125. Mancia G, Facchetti R, Parati G, Hypertension measurement in humans: a dipping circadian Blood Hypertension and ZanchettiA. Visit-to-visitbloodpressure statement for professionals from the renal impairment are associated with variability in the European Lacidipine SubcommitteeofProfessionalandPublic increasedmortalityindiabetesmellitus. StudyonAtherosclerosis: methodologiEducation of the American Heart AssoDiabetMed2000; 17: 360364 cal aspects and effects of antihypertenciationCouncilonHighBloodPressure 114. Nakano S, Ito T, Furuya potassium, et al. Amsive treatment. J Hypertens 2012; 30: Research. Hypertension 2005; 45: 142 bulatorybloodpressurelevelratherthan 12411251 161 dipper/nondipperstatuspredictsvascu126. Stergiou GS, Nasothimiou EG. Home 102. Lurbe E, Redon J, Kesani A, et al. Inlar events in type 2 diabetic subjects.",
    "word_count": 584,
    "char_count": 5013,
    "sentence_count": 71,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 13,
      "total_chunks": 16,
      "position": "14/16",
      "content_type": "evidence",
      "content_type_confidence": 3,
      "medical_entities": [
        "nephropathy",
        "albuminuria",
        "potassium",
        "calcium",
        "monitoring"
      ],
      "entity_count": 5
    }
  },
  {
    "chunk_id": 14,
    "text": "Home 102. Lurbe E, Redon J, Kesani A, et al. Inlar events in type 2 diabetic subjects. monitoring is the optimal method for crease in nocturnal Blood Hypertension and HypertensRes2004; 27: 647656 assessing Blood Hypertension variability. progressiontomicroalbuminuriaintype 115. Muntner P, Joyce C, Levitan EB, et al. HypertensRes2011; 34: 12461248 1diabetes. NEnglJMed2002; 347: 797 Reproducibility of visit-to-visit variabil127. Masugata H, Senda S, Murao potassium, et al. 805 ityofbloodpressuremeasuredaspartof Visit-to-visitvariabilityinbloodpressure 103. Metoki H, Ohkubo T, Kikuya M, et al. routine clinicalcare. JHypertens 2011; over a 1-year period is a marker of Prognostic significance for stroke of a 29: 23322338 left ventricular diastolic dysfunction in morning pressor surge and a nocturnal 116. RothwellPM, HowardSC, DolanE, etal. treatedhypertensivepatients. Hypertens Blood Hypertension decline: the Ohasama Prognostic significance of visit-to-visit Res2011; 34: 846850 study. Hypertension2006; 47: 149154 variability, maximum systolic Blood 128. Nagai M, Hoshide S, Ishikawa J, 104. Ohkubo T, Hozawa A, Yamaguchi J, Hypertension, and episodic hypertension. ShimadaK, KarioK. Visit-to-visitblood et al. Prognostic significance of the Lancet2010; 375: 895905 Hypertension variations: new independent care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S323 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome determinantsforcarotidarterymeasures 136. Hata Y, Muratani H, Kimura Y, et al. ambulatorybloodpressurefromtheIrin the elderly at High risk of cardiovasOffice Blood Hypertension variability as a besartaninPatientswithType2Diabetes culardisease. JAmSocHypertens2011; predictorofacutemyocardialinfarction and Microalbuminuria study. Diabetes 5: 184192 in elderly patients receiving antihyperCare2003; 26: 569574 129. KilpatrickES, RigbyAS, AtkinSL. Therole tensivetherapy. JHumHypertens2002; 143. PoulsenPL, EbbehjE, NosadiniR, etal. of Blood Hypertension variability in the de16: 141146 Early angiotensin-converting enzyme inhibitor intervention in microvelopment of nephropathy in type 1 di137. GroveJS, ReedDM, YanoK, HwangLJ. albuminuric patients with type 1 diabetes. DiabetesCare2010; 33: 24422447 Variability in systolic Blood pressured abetes: effectsonalbuminexcretion, 24 130. KawaiT, OhishiM, KamideK, etal. The ariskfactorforcoronaryheartdisease? hambulatorybloodpressure, andrenal impact of visit-to-visit variability in AmJEpidemiol1997; 145: 771776 function. DiabetesMetab2001; 27: 123 Blood Hypertension on renal function. Hy138. Okada H, Fukui M, Tanaka M, et al. 128 pertensRes2012; 35: 239243 Visit-to-visitvariabilityinsystolicblood 144. FrattolaA, ParatiG, CastiglioniP, etal. 131. Brickman AM, Reitz C, Luchsinger JA, Hypertension is correlated with diabetic neLacidipineandbloodpressurevariability etal. Long-termbloodpressurefluctuaphropathyandatherosclerosisinpatients in diabetic hypertensive patients. Hytion and cerebrovascular disease in an withtype2diabetes. Atherosclerosis2012; pertension2000; 36: 622628 elderly cohort. Arch Neurol 2010; 67: 220: 155159 145. Masuda S, Tamura potassium, Wakui H, et al. 564569 139. RizzoniD, MuiesanML, SalvettiM, etal. EffectsofangiotensinIItype1receptor 132. Diaz KM, Veerabhadrappa P, Kashem The smoothness index, but not the blocker on ambulatory Blood Hypertension MA, et al. Relationship of visit-to-visit trough-to-peakratiopredictschangesin variabilityinhypertensivepatientswith and ambulatory Blood Hypertension varicarotidarterywallthicknessduringanti- overt diabetic nephropathy. Hypertens ability to vascular function in African hypertensive treatment. J Hypertens Res2009; 32: 950955 Americans. HypertensRes2012; 35: 5561 2001; 19: 703711 146. Mancia G, Facchetti R, Parati G, 133. Hata Y, Kimura Y, Muratani H, 140. Anan F, Masaki T, Fukunaga N, et al. ZanchettiA. Visit-to-visitbloodpressure Fukiyama potassium, Kawano Y, Ashida T, Pioglitazone shift circadian rhythm of variability, carotid atherosclerosis, and Yokouchi M, Imai Y, Ozawa T, Fujii J bloodpressurefromnon-dippertodipcardiovascular events in the European etal: Officebloodpressurevariabilityasa pertypeintype2diabetesmellitus. EurJ Lacidipine Study on Atherosclerosis. predictor of brain infarction in elderly ClinInvest2007; 37: 709714 Circulation2012; 126: 569578 hypertensive patients. Hypertens Res 141. KomajdaM, CurtisP, HanefeldM, etal. ; 147. WebbAJ, FischerU, MehtaZ, Rothwell 2000; 23: 553560 RECORD Study Group. Effect of the PM. Effects of antihypertensive-drug 134. Rothwell PM, Howard SC, Dolan E, additionofrosiglitazonetometforminor class on interindividual variation in etal. ; ASCOT-BPLAandMRCTrialInsulfonylureas versus metformin/sulfobloodpressureandriskofstroke: asysvestigators. Effectsofbetablockersand nylureacombinationtherapyonambutematicreviewandmeta-analysis. Lancet calcium-channel blockers on withinlatorybloodpressureinpeoplewithtype 2010; 375: 906915 individual variability in Blood Hypertension 2diabetes: arandomizedcontrolledtrial 148. TurnbullF, NealB, AlgertC, etal. ; Blood andriskofstroke. LancetNeurol2010; 9: (the RECORD study). Cardiovasc DiaHypertension Lowering Treatment Trialists 469480 betol2008; 7: 10 Collaboration. Effectsofdifferentblood 135.",
    "word_count": 597,
    "char_count": 5314,
    "sentence_count": 81,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 14,
      "total_chunks": 16,
      "position": "15/16",
      "content_type": "evidence",
      "content_type_confidence": 5,
      "medical_entities": [
        "renal function",
        "nephropathy",
        "potassium",
        "calcium",
        "antihypertensive",
        "monitoring"
      ],
      "entity_count": 6
    }
  },
  {
    "chunk_id": 15,
    "text": "; Blood andriskofstroke. LancetNeurol2010; 9: (the RECORD study). Cardiovasc DiaHypertension Lowering Treatment Trialists 469480 betol2008; 7: 10 Collaboration. Effectsofdifferentblood 135. Eguchi potassium, Hoshide S, Schwartz JE, 142. RossingK, ChristensenPK, AndersenS, Hypertension-lowering regimens on major Shimada potassium, Kario potassium. Visit-to-visit and Hovind P, Hansen HP, Parving HH; Ircardiovasculareventsinindividualswith ambulatorybloodpressurevariabilityas besartaninPatientswithType2Diabetes and without Diabetes mellitus: results predictors of incident cardiovascular and Microalbuminuria Study. Comparof prospectively designed overviews of eventsinpatientswithhypertension. Am ativeeffectsofIrbesartanonambulatory randomized trials. Arch Intern Med JHypertens2012; 25: 962968 andofficebloodpressure: asubstudyof 2005; 165: 14101419 S324 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025",
    "word_count": 98,
    "char_count": 981,
    "sentence_count": 12,
    "metadata": {
      "source_file": "s312.pdf",
      "extraction_date": "2025-12-31T14:19:36.731476",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "renal"
      ],
      "chunk_index": 15,
      "total_chunks": 16,
      "position": "16/16",
      "content_type": "evidence",
      "content_type_confidence": 4,
      "medical_entities": [
        "potassium"
      ],
      "entity_count": 1
    }
  }
]